INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
LL

Lupher, Jr. Mark L.

DirectorCIK 0001775323

EDGAR filingsOpen in network
Disclosed transactions9
Buys / sells0 / 0
Max Insider Score9
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
4,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Adverum Biotechnologies, Inc.Director · Dec 10, 2025
9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D
—
7,000 sh
Dec 9, 2025
Dec 10, 2025
traded Dec 9, 2025
+1d
SEC FORM 4

Evidence

9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
4,500 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
3,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
4,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
10.5K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
10.4K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Tender of shares
U—
13.0K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
4,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence